Merck & Co Inc (NYSE: MRK) Q4 2020 earnings call dated Feb. 04, 2021
Corporate Participants:
Peter Dannenbaum — Vice President, Investor Relations
Kenneth C. Frazier — Chairman of the Board and Chief Executive Officer
Robert M. Davis — Executive Vice President, Global Services, and Chief Financial Officer
Dean Y. Li — Executive Vice President and President, Merck Research Laboratories
Michael T. Nally — Executive Vice President and Chief Marketing Officer
Analysts:
Seamus Fernandez — Guggenheim Partners — Analyst
Andrew Baum — Citi — Analyst
Terence Flynn — Goldman Sachs — Analyst
Chris Schott — JPMorgan — Analyst
Louise Chen — Cantor — Analyst
David Risinger — Morgan Stanley — Analyst
Daina Graybosch — SVB Leerink — Analyst
Umer Raffat — Evercore ISI — Analyst
Steve Scala — Cowen — Analyst
Navin Jacob — UBS — Analyst
Gregg Gilbert — Truist — Analyst
Mara Goldstein — Mizuho — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
Listen On
